Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass

OBJECTIVE: The human acellular vessel (HAV) was evaluated for surgical bypass in a phase II study. The primary results at 24 months after implantation have been reported, and the patients will be evaluated for ≤10 years. METHODS: In the present report, we have described the 6-year results of a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutowski, Piotr, Guziewicz, Malgorzata, Ilzecki, Marek, Kazimierczak, Arkadiusz, Lawson, Jeffrey H., Prichard, Heather L., Przywara, Stanislaw, Samad, Rabih, Tente, William, Turek, Jakub, Witkiewicz, Wojcieh, Zapotoczny, Norbert, Zubilewicz, Tomaz, Niklason, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976461/
https://www.ncbi.nlm.nih.gov/pubmed/36874956
http://dx.doi.org/10.1016/j.jvssci.2022.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976461/
https://www.ncbi.nlm.nih.gov/pubmed/36874956
http://dx.doi.org/10.1016/j.jvssci.2022.11.001

Ejemplares similares